Results 261 to 270 of about 77,929 (279)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

Nature Genetics, 2011
Grazyna Kochan, Alexander T Dilthey, Matti Pirinen   +2 more
exaly  

Ankylosing spondylitis

Postgraduate Medicine, 1972
openaire   +2 more sources

ANKYLOSING SPONDYLITIS AND HL-A 27

Lancet, The, 1973
exaly  

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Lancet, The, 2018
Désirée M Van Der Heijde, James C-C Wei, Maxime Dougados   +2 more
exaly  

ANKYLOSING SPONDYLITIS

The Lancet, 1947
openaire   +1 more source

Ankylosing Spondylitis

Proceedings of the Royal Society of Medicine, 1966
openaire   +2 more sources

Pathogenesis of ankylosing spondylitis — recent advances and future directions

Nature Reviews Rheumatology, 2017
Eric Gracey, Matthew A Brown, Nigil Haroon Mbbs,, Dm   +2 more
exaly  

OSTEOPOROSIS IN EARLY ANKYLOSING SPONDYLITIS: A PRIMARY PATHOLOGICAL EVENT?

Lancet, The, 1989
exaly  

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

Lancet, The, 1993
exaly  

INHERITANCE OF ANKYLOSING SPONDYLITIS AND HL-A ANTIGEN W27

Lancet, The, 1974
exaly